Evidence map›Paper›PMID 28713248›Full record

ArticleFrontiers in neural circuits2017

Deep Brain Magnetic Stimulation Promotes Neurogenesis and Restores Cholinergic Activity in a Transgenic Mouse Model of Alzheimer's Disease.

Junli Zhen, Yanjing Qian, Jian Fu, Ruijun Su, Haiting An, Wei Wang, Yan Zheng, Xiaomin Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neural circuits, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Antioxidants (Basel, Switzerland) · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Junli ZhenDepartment of Neurobiology, Key Laboratory for Neurodegenerative Disorders of the Ministry of Education, Capital Medical UniversityBeijing, China.
Yanjing QianDepartment of Neurobiology, Key Laboratory for Neurodegenerative Disorders of the Ministry of Education, Capital Medical UniversityBeijing, China.
Jian FuThe Second Hospital of Hebei Medical UniversityShijiazhuang, China.
Ruijun SuDepartment of Neurobiology, Key Laboratory for Neurodegenerative Disorders of the Ministry of Education, Capital Medical UniversityBeijing, China.
Haiting AnDepartment of Neurobiology, Key Laboratory for Neurodegenerative Disorders of the Ministry of Education, Capital Medical UniversityBeijing, China.
Wei WangDepartment of Neurobiology, Key Laboratory for Neurodegenerative Disorders of the Ministry of Education, Capital Medical UniversityBeijing, China.
Yan ZhengDepartment of Neurobiology, Key Laboratory for Neurodegenerative Disorders of the Ministry of Education, Capital Medical UniversityBeijing, China.
Xiaomin WangDepartment of Neurobiology, Key Laboratory for Neurodegenerative Disorders of the Ministry of Education, Capital Medical UniversityBeijing, China.
Chinese Institute for Brain Research · CNCapital Medical University · CNSecond Hospital of Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is characterized by progressive decline of memory and cognitive functions. Deep magnetic stimulation (DMS), a noninvasive and nonpharmacological brain stimulation, has been reported to alleviate stress-related cognitive impairment in neuropsychiatric disorders. Our previous study also discovered the preventive effect of DMS on cognitive decline in an AD mouse model. However, the underlying mechanism must be explored further. In this study, we investigated the effect of DMS on spatial learning and memory functions, neurogenesis in the dentate gyrus (DG), as well as expression and activity of the cholinergic system in a transgenic mouse model of AD (5XFAD). Administration of DMS effectively improved performance in spatial learning and memory of 5XFAD mice. Furthermore, neurogenesis in the hippocampal DG of DMS-treated 5XFAD mice was clearly enhanced. In addition, DMS significantly raised the level of acetylcholine and prevented the increase in acetylcholinesterase activity as well as the decrease in acetyltransferase activity in the hippocampus of 5XFAD mice. These findings indicate that DMS may be a promising noninvasive tool for treatment and prevention of AD cognitive impairment by promoting neurogenesis and enhancing cholinergic system function.

Indexed as

Magnetic Field TherapyAcetylcholineAcetylcholinesteraseAlzheimer DiseaseAmyloid beta-Protein PrecursorAnimalsCholine O-AcetyltransferaseDisease Models, AnimalHippocampusHumansMice, Inbred C57BLMice, TransgenicNeurogenesisPresenilin-1Random AllocationSpatial LearningAcetylcholineAcetylcholinesteraseAmyloid beta-Protein PrecursorAPP protein, humanCholine O-AcetyltransferasePresenilin-1PSEN1 protein, humanAlzheimer’s diseasecholinergic activitycognitionhippocampusneurogenesis

Identifiers

PMID28713248
PMCPMC5492391
OpenAlexW2731965030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.